Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Biochemical Pharmacology|April 15, 1987
Inhibition of human purine nucleoside phosphorylase by acyclic nucleosides and nucleotidesJ M Stein, J D Stoeckler, S Y Li, et al.Infection and Immunity|December 1, 1992
Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complexP P Vella, S Marburg, J M Staub, et al.Cellular Immunology|March 1, 1988
5-Halo-6-phenyl pyrimidinones and 8-substituted guanosines: biological response modifiers with similar effects on B cellsL S Wicker, W T Ashton, R C Boltz, et al.Virology|April 1, 1993
Identification of HIV vaccine candidate peptides by screening random phage epitope librariesP M Keller, B A Arnold, A R Shaw, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replicationA K Field, M E Davies, C DeWitt, et al.Investigative Ophthalmology & Visual Science|September 1, 1993
Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMPS Shakiba, K K Assil, A D Listhaus, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 1, 1996
MK386: a potent, selective inhibitor of the human type 1 5alpha-reductaseK Ellsworth, B Azzolina, W Baginsky, et al.Journal of Medicinal Chemistry|July 1, 1985
Synthesis and antiherpetic activity of (S)-, (R)-, and (+/-)-9-[(2,3-dihydroxy-1-propoxy)methyl]guanine, linear isomers of 2'-nor-2'-deoxyguanosineW T Ashton, L F Canning, G F Reynolds, et al.Journal of Medicinal Chemistry|May 29, 1992
Renin inhibitors containing C-termini derived from mercaptoheterocyclesW T Ashton, C L Cantone, L C Meurer, et al.Journal of Medicinal Chemistry|October 1, 1980
Ivermectin, a new broad-spectrum antiparasitic agentJ C Chabala, H Mrozik, R L Tolman, et al.Pageof 5